Live Breaking News & Updates on Diagnostics

Stay informed with the latest breaking news from Diagnostics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Diagnostics and stay connected to the pulse of your community

Owlstone Medical secures $6.5 million to support development of breath-based diagnostics for infectious disease

Funding represents the first time the foundation has taken an equity position in a breath diagnostics company.

United-kingdom , South-africa , University-of-cape-town , Western-cape , Billy-boyle , Gates-foundation , Melinda-gates-foundation-the , Us-department-of-defense , Oxford-university , Imperial-college , Owlstone-medical , Breath-biopsy

Quest adds pTau217 to Alzheimer's test portfolio

Quest Diagnostics Inc. expanded its Alzheimer’s disease (AD) portfolio with a blood-based biomarker test for phosphorylated tau 217 (pTau217). The test joins the company’s plasma tests for p-tau181, beta-amyloid 42/40 ratio and ApoE genetic risk as well as several cerebrospinal fluid tests for Alzheimer’s.

Quest-diagnostics-inc , Quest-diagnostics , Helmholtz-diabetes-center , Cachexia , Cancer-induced-cachexia , Penx-acip , Bioworld-medtech , Quest-diagnostics-inc- , Alzheimers-disease , Ptau-217 , P-tau217

Large-scale study identifies new approach to early Alzheimer's detection

Digital memory test and a blood sample - this combination will be tested for its potential to identify early Alzheimer's disease in a new research study. Over a hundred healthcare centers are part of the study that is now inviting participants to sign up. At least 3,000, preferably many more participants are needed for the study to be successful.

Finland , Sweden , Gothenburg , Vastra-gotalands-lan , Swedish , Finnish , Silke-kern , Kaj-blennow , Henrik-zetterberg , Gothenburg-university , Sahlgrenska-academy , Sahlgrenska-university-hospital

Quest Diagnostics Q1 2024 Earnings: Aligns with Analyst EPS Projections, Raises Full-Year Guidance

Comprehensive Analysis of Quest Diagnostics' Latest Financial Performance

Jim-davis , Quest-diagnostics-inc , Diagnostics-research , Quest-diagnostics , Medical-diagnostics , Financial-guidance , Diagnostics , Edical-diagnostics , Iagnostic-testing ,

Hologic expects facility closures in diagnostics division

MedTech industry news

Massachusetts , United-states , Connecticut , Delaware , Karleen-oberton , Medtech-dive , Bridget-perry , Chief-financial-officer-karleen-oberton , Wall-street-journal , Diagnostics ,

Sound decision: Masimo to split off consumer business

Less than two years after acquiring Sound United for $1.025 billion, Masimo Corp. plans to hive off the consumer audio subsidiary along with consumer health products such as its Stork baby monitor and Freedom smart watch and band. The “rushed” announcement made Friday “came after being informed that Politan intended to nominate directors this week,” said activist investor Politan Capital Management. Politan, which owns 8.9% of the company, secured two board seats in a highly contentious proxy battle last year and nominated two more on Monday morning.

Masimo-corp , Sound-united , Politan-capital , Bioworld-medtech , Masimo-corp- , Spin-off , Sound-united-llc , Apple-inc- , Diagnostics , Us- , Deals-andm-amp-a

Alamar Biosciences scoops up $128M for proteomics platform

Alamar Biosciences Inc.’s substantially oversubscribed series C pushed the company’s total funds raised to $250 million. The company closed the first $100 million on Feb. 26 and expects to close an additional $28 million within 30 days. The target for the series C was $100 million. The funds will be used to drive market adoption of its Argo HT system and nucleic acid linked immune-sandwich assay sequencing (NULISAseq) inflammation panel 250 for deep profiling of immune response.

Alamar-biosciences-inc , Alamar-biosciences , Bioworld-medtech , Alamar-biosciences-inc- , Argo-ht , Nulisa , Nulisaseq-250 , Biomarkers , Series-c , Us- , Diagnostics

Innovative Subak tool offers affordable solution for detecting nuclease digestion

A new tool could reduce costs for diagnosing infectious diseases.

Austin-college , Texas , United-states , Soonwoo-hong , Jennifer-brodbelt , Tim-yeh , Minjun-kim , Ut-austin-college-of-natural-sciences , Southern-methodist-university-lyle-school-of-engineering , National-science-foundation , Fluorescence-resonance-energy-transfer , University-of-texas-at-austin

AI in Diagnostics: Revolution or Evolution? - Indian News |

Discover the impact of artificial intelligence (AI) in diagnostics and medicine. Explore the integration of AI into the diagnostic process, examples of AI in diagnostic procedures, and the future of diagnostic medicine with AI advancements.

Shibu-vijayan , Medical , Healthcare , Dr-shibu-vijayan , Diagnostics , Artificial-intelligence , Ai ,

Freenome liberated with $254M infusion for cancer testing

If Freenome Holdings Inc.’s $254 million funding round is a sign, the capital markets for med-tech may finally be thawing. The cancer diagnostics company’s latest cash infusion brings its total funds raised to date to more than $1.3 billion. Freenome co-founder and Chief Product Officer Riley Ennis told BioWorld the company’s success in raising cash in a challenging market was attributable to the “perfect storm of huge unmet need and the opportunity that we have, given the treatment advancements.”

Riley-ennis , Freenome-holdings-inc , Freenome-holdings , Chief-product-officer-riley-ennis , Bioworld-medtech , Freenome-inc- , Freenome-holdings-inc- , Liquid-biopsy , Cancer-screening , Quest-diagnostics-inc- , Roche-holding-ag , Oncology